Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/26/21 13:30 | 11/23/21 | DRMA | Health | Drug | Pharmaceutical Preparations | Proehl Gerald T | CA | DOT | P,CEO,CB | P | 48 | 2.40 | 0 | 20 | 1 | 3,180 | D | ||||||||||||||
8/17/21 12:49 | 8/17/21 | DRMA | Health | Drug | Pharmaceutical Preparations | Hale David F | CA | DT | P.d | 0 | 0.00 | 0 | 36 | 7 | 584 | I | |||||||||||||||
8/17/21 12:38 | 8/16/21 | DRMA | Health | Drug | Pharmaceutical Preparations | Proehl Gerald T | CA | DOT | P,CEO,CB | P.dm | 50 | 0.3247 | 0 | 153 | 5 | 3,160 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |